Visual compatibility of injectable drugs used in the intensive care unit

American Journal of Health-System Pharmacy

Volumn 54, Issue 1, 1997, Pages 64-65

  Chiu, Ming Fung ^a   Schwartz, Mitchell Lee ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DILTIAZEM; DOBUTAMINE; DOPAMINE; FENTANYL CITRATE; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; HYDROMORPHONE; LABETALOL; LORAZEPAM; MIDAZOLAM; MILRINONE; MORPHINE SULFATE; NICARDIPINE; NORADRENALIN; RANITIDINE; THIOPENTAL; VECURONIUM;

ARTICLE; DRUG INCOMPATIBILITY; DRUG MIXTURE; DRUG SOLUBILITY; DRUG STABILITY; INTENSIVE CARE UNIT; PRECIPITATION; PRIORITY JOURNAL;

EID: 1842337500     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/54.1.64     Document Type: Article

References (4)

1. Allen LV Jr, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43.
2. Allen LV Jr, Stiles ML. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2. Am J Hosp Pharm. 1981; 38:380-1.
3. Gasca M, Fanikos J, Souney PF. Visual compatibility of perphenazine with various antimicrobials during simulated Y-site injection. Am J Hosp Pharm. 1987; 44:574-5.
4. Trissel LA. Handbook on injectable drugs. 7th ed. Bethesda, MD: American Society of Hospital Pharmacists; 1992.